Experimental Drug Lowers Parkinson’s-Linked Protein in Early Trial

“An experimental drug designed to silence a gene strongly linked to Parkinson’s disease has shown encouraging effects in a first-in-human clinical trial, according to a study published in Nature Medicine. The post Experimental Drug Lowers Parkinson’s-Linked Protein in Early Trial appeared first on News Center .

Summary generated from the RSS feed of Northwestern Feinberg News. All article rights belong to the original publisher. Click through to read the full piece on news.feinberg.northwestern.edu.